Taro Settles DOJ Price Fixing Charges, Will Pay $205M Penalty

Law360 (July 23, 2020, 9:19 PM EDT) -- Generics maker Taro Pharmaceuticals U.S.A. Inc. has agreed to pay a $205.7 million criminal penalty to settle charges that it conspired to fix prices, the U.S. Department of Justice said Thursday, in the 10th case stemming from the agency's ongoing investigation into the industry.

The DOJ's Antitrust Division said that Taro has entered a deferred prosecution agreement in Pennsylvania federal court for a two-count felony charge over allegations the company participated in a pair of conspiracies with competing manufacturers, including one with generics heavyweight Sandoz Inc.

Taro admitted to reaping more than $500 million in sales connected to the conduct and...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!